Navigation Links
IRIS Medical IQ 810 Infrared Laser

ProductsIRIS Medical IQ 810 Infrared Laser
Company IRIDEX
Item IRIS Medical IQ 810 Infrared Laser
Features 
  • SmartWare interactive software with customizable settings, advanced waveform capability
  • FiberCheck Slit Lamp Adapter delivery device.
  • SmartWare interactive software for intuitive set up and operation of the laser, customization of laser output and settings, and integrated system diagnostics.
  • SmartWare enables quick access to CW-Pulse (continuous wave), MicroPulse, and LongPulse operating modes as well as advanced pulse modalities, Group and PowerStep, for precise control and laser energy output customization with developing protocols.
  • The IQ 810 is lightweight and portable, facilitating easy transport of the device from room-to-room or clinic-to-clinic. The intelligently designed internal circuitry results in precise pulse timing, power stability and consistent laser mode quality.
  • The IQ 810 is compatible with a variety of IRIS Medical delivery devices including the FiberCheck Slit Lamp Adapter (SLA), Laser Indirect Ophthalmoscope, G-Probe, DioPexy Probe and family of EndoProbe handpieces to maximize clinical versatility.
  • The FiberCheck feature for the SLA is unique and new to the IQ 810 and allows the doctor to quickly and easily verify the integrity of the fiber before treatment which is increasingly important with the adoption of MIP procedures where endpoints are not visible.
Description The new solid-state IRIS Medical IQ 810 infrared diode laser photocoagulator for the treatment of retinal disorders and glaucoma. The Companys top-of-the-line, solid-state system represents its latest technological innovation and is designed to perform traditional and Minimum Intensity Photocoagulation (MIP) procedures in the office and operating room settings. In addition, the IQ 810 increases the clinical versatility available to ophthalmologists today with its SmartWare interactive software with customizable settings, advanced waveform capability, and unique FiberCheck Slit Lamp Adapter delivery device.

The IQ 810 features SmartWare interactive software for intuitive set up and operation of the laser, customization of laser output and settings, and integrated system diagnostics. SmartWare enables quick access to CW-Pulse (continuous wave), MicroPulse, and LongPulse operating modes as well as advanced pulse modalities, Group and PowerStep, for precise control and laser energy output customization with developing protocols.

Info IRIDEX
Customer Service: (800) 388-9087

Related medicine products :

1. Disposable Medical Penlight
2. MaximEyes Practice Management and Electronic Medical Records Software Solutions
3. Sony LMD-181MD Medical Grade LCD
4. Sony LMD-151MD Medical Grade LCD
5. Sony PVM-20M2MDU Medical Grade Monitor
6. Sony PVM-14M2MDU Medical Grade Monitor
7. PRAXIS® Electronic Medical Records v. 2.19
8. TTI Medical Digital Video Disk Recorder
9. TTI Medical Medicap Still Image Capture
10. First-Call Medical Monitoring Services
11. 7121B Sony Medical Monitor
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
BD Vacutainer® Specialty Tubes - Acid Citrate Dextrose (ACD)...
... BD Vacutainer® SST™ Tubes ... a polymer gel for ... used for serum determinations ... provide an efficient means ...
MONOJECT Red/Yellow Mottled Stopper...
Medicine Products:
(Date:4/22/2014)... in massive health care spending, a new RAND study ... to incentivize pharmaceutical companies and device makers to develop ... existing medical technologies and their use, a new study ... and medical devices get created in the first place. ... with as little loss of health as possible and ...
(Date:4/22/2014)... Mich. Nearly 7 in 10 Americans support ... new national survey by researchers at the University of ... children under the age of 18 at home, and ... likely than other adults to support universal coverage of ... in the Journal of the American Medical Association ...
(Date:4/22/2014)... This news release is available in German . ... F. Perutz Laboratories of the University of Vienna and the ... Zurich, have now shown how double stranded RNA, such as ... a cell. During the immune response against viral infection, the ... cytoplasm. There it modifies viral RNA to inhibit reproduction of ...
(Date:4/22/2014)... When mothers are exposed to trauma, illness, alcohol or ... molecular trigger in brain cells that can go awry ... and some forms of autism. , Until now, it ... the cells of a developing brain. Past studies have ... alcohol or drug abuse or she experiences some trauma ...
(Date:4/22/2014)... chronic inflammatory disorders of the intestine that result in ... in the U.S., and while there are treatments to ... , Now, Cincinnati Cancer Center and University of Cincinnati ... in her lab have done what is believed to ... important function for the Ron receptor, a cell surface ...
Breaking Medicine News(10 mins):Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Life stressors trigger neurological disorders, researchers find 2Health News:Two genes linked to inflammatory bowel disease 2
... the only over the counter treatment for chronic and acute wounds. ... contamination of wounds and speeds up the healing process. ... ... development of Wound-Be-Gone, all skin injuries, especially large, chronic wounds, can ...
... WASHINGTON, Nov. 18 Over 2 million low-income Medicare,beneficiaries ... in,January. Changes to the 2009 Medicare Part D plans ... premiums they cannot afford or limit,access to their prescriptions, ... Law Center (NSCLC). Part D open enrollment runs from ...
... But research is preliminary, scientists stress , , TUESDAY, Nov. ... a genetic trait that could provide an early indication ... The research, reported Tuesday at the American Association for ... the preliminary stages. , Still, "the benefit would hopefully ...
... A study appearing in Journal of the American ... their healthcare benefits may affect their ability to access ... delay or avoid seeking care. , In the ... across the United States were surveyed. About one-third of ...
... Resource So Families of ,Bad, Children Can Survive - and ... BEACH, Fla., Nov. 18 The holidays should bring peace, ... the season can foster difficult, even disorderly conduct among troubled ... a family gathering and leave parents asking, "What did I ...
... SEATTLE, Nov. 18 Seattle University ... million Opus Prize to Marguerite "Maggy",Barankitse for her ... of,ethnic strife in Burundi, Africa. Two $100,000 winners ... Community and Center for the,Development of Central America, ...
Cached Medicine News:Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 2Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 3Health News:2009 Medicare Part D Premiums to Rise Dramatically: Over 2 Million Low Income Beneficiaries At Risk 2Health News:Genetic Trait Could Predict Lung Cancer 2Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 2Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 3Health News:Seattle University in Partnership With the Opus Prize Foundation Award $1 Million Opus Prize 2
(Date:1/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ... stock of Solta Medical, Inc. (NASDAQ: SLTM ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... results for the fourth quarter of 2013 on Monday, February ... for release after the close of trading. ... conference call to discuss the operating highlights and financial results ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3